Polar Asset Management Partners Inc. Dexcom Inc Transaction History

Polar Asset Management Partners Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$75.49 - $124.16 $3 Million - $4.94 Million	-39,800 Reduced 16.7%	198,500 $24.6 Million
Q3 2023 Nov 14, 2023	BUY	$86.06 - $137.93 $20.5 Million - $32.9 Million	238,300 New	238,300 $22.2 Million
Q1 2023 May 15, 2023	SELL	$104.0 - $122.92 $9.03 Million - $10.7 Million	-86,800 Reduced 37.64%	143,800 $16.7 Million
Q4 2022 Feb 14, 2023	SELL	$84.98 - $122.67 $5.57 Million - $8.03 Million	-65,500 Reduced 22.12%	230,600 $26.1 Million
Q3 2022 Nov 14, 2022	SELL	$76.35 - $94.18 $12.3 Million - $15.2 Million	-161,400 Reduced 35.28%	296,100 $23.8 Million
Q2 2022 Aug 15, 2022	BUY	$67.99 - $132.89 $27 Million - $52.8 Million	397,200 Added 658.71%	457,500 $34.1 Million
Q1 2022 May 16, 2022	BUY	$94.08 - $130.2 $4.34 Million - $6 Million	46,100 Added 324.65%	60,300 $30.8 Million
Q4 2021 Feb 14, 2022	BUY	$129.87 - $162.82 $1.84 Million - $2.31 Million	14,200 New	14,200 $7.63 Million
Q3 2021 Nov 15, 2021	SELL	$106.71 - $143.18 $2.44 Million - $3.28 Million	-22,900 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$80.99 - $107.93 $1.85 Million - $2.47 Million	22,900 New	22,900 $9.78 Million

1,016

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $30.2B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.